Evaluation Of The Rate Of Pathological Complete Response (pCR) For Neoadjuvant Chemoradiotherapy (CT-RT) And For Chemotherapy (CT) Alone in Locally Advanced Non Small Cell Lung Cancer (LA-NSCLC): A Randomized Phase II trial
Evaluation Of The Rate Of Pathological Complete Response (pCR) For Neoadjuvant Chemoradiotherapy (CT-RT) And For Chemotherapy (CT) Alone in Locally Advanced Non Small Cell Lung Cancer (LA-NSCLC): A Randomized Phase II trial
Evaluation Of The Rate Of Pathological Complete Response (pCR) For Neoadjuvant Chemoradiotherapy (CT-RT) And For Chemotherapy (CT) Alone in Locally Advanced Non Small Cell Lung Cancer (LA-NSCLC): A Randomized Phase II trial
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
75
Years old
Gender
All
Therapeutic area :
Oncology
Disease :
Non small cell lung cancer (NSCLC)
Study medication :
Vinorelbine (Navelbine® Oral)
Phase :
Phase II
Start Date :
26 June 2007
End date :
05 December 2007
Study ID :
PM0259 CA 224 J1
EudraCT/CTIS number :
2005-005139-84
Send by email